vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and XPLR Infrastructure, LP (XIFR). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $249.0M, roughly 2.0× XPLR Infrastructure, LP). XPLR Infrastructure, LP runs the higher net margin — 11.2% vs 6.8%, a 4.4% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -15.3%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -1.6%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
XPLR Infrastructure is a publicly traded subsidiary of NextEra Energy, is a Juno Beach, Florida-based renewable energy company.
MD vs XIFR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $493.8M | $249.0M |
| Net Profit | $33.7M | $28.0M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | -19.3% |
| Net Margin | 6.8% | 11.2% |
| Revenue YoY | -1.7% | -15.3% |
| Net Profit YoY | 10.5% | 124.3% |
| EPS (diluted) | $0.40 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $249.0M | ||
| Q3 25 | $492.9M | $315.0M | ||
| Q2 25 | $468.8M | $342.0M | ||
| Q1 25 | $458.4M | $282.0M | ||
| Q4 24 | $502.4M | $294.0M | ||
| Q3 24 | $511.2M | $319.0M | ||
| Q2 24 | $504.3M | $360.0M | ||
| Q1 24 | $495.1M | $257.0M |
| Q4 25 | $33.7M | $28.0M | ||
| Q3 25 | $71.7M | $-37.0M | ||
| Q2 25 | $39.3M | $79.0M | ||
| Q1 25 | $20.7M | $-98.0M | ||
| Q4 24 | $30.5M | $-115.0M | ||
| Q3 24 | $19.4M | $-40.0M | ||
| Q2 24 | $-153.0M | $62.0M | ||
| Q1 24 | $4.0M | $70.0M |
| Q4 25 | 9.9% | -19.3% | ||
| Q3 25 | 13.8% | 1.6% | ||
| Q2 25 | 12.8% | 26.3% | ||
| Q1 25 | 7.0% | -82.6% | ||
| Q4 24 | 7.8% | -188.1% | ||
| Q3 24 | 6.6% | 15.4% | ||
| Q2 24 | -31.3% | 18.3% | ||
| Q1 24 | 3.2% | -8.2% |
| Q4 25 | 6.8% | 11.2% | ||
| Q3 25 | 14.5% | -11.7% | ||
| Q2 25 | 8.4% | 23.1% | ||
| Q1 25 | 4.5% | -34.8% | ||
| Q4 24 | 6.1% | -39.1% | ||
| Q3 24 | 3.8% | -12.5% | ||
| Q2 24 | -30.3% | 17.2% | ||
| Q1 24 | 0.8% | 27.2% |
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.84 | $-0.40 | ||
| Q2 25 | $0.46 | $0.84 | ||
| Q1 25 | $0.24 | $-1.05 | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.23 | $-0.43 | ||
| Q2 24 | $-1.84 | $0.66 | ||
| Q1 24 | $0.05 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $960.0M |
| Total DebtLower is stronger | $570.5M | $6.2B |
| Stockholders' EquityBook value | $865.9M | $10.9B |
| Total Assets | $2.2B | $19.6B |
| Debt / EquityLower = less leverage | 0.66× | 0.57× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $960.0M | ||
| Q3 25 | $340.1M | $711.0M | ||
| Q2 25 | $224.7M | $880.0M | ||
| Q1 25 | $99.0M | $1.5B | ||
| Q4 24 | $229.9M | $283.0M | ||
| Q3 24 | $103.8M | $290.0M | ||
| Q2 24 | $19.4M | $281.0M | ||
| Q1 24 | $8.0M | $245.0M |
| Q4 25 | $570.5M | $6.2B | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | $5.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $10.9B | ||
| Q3 25 | $890.7M | $11.0B | ||
| Q2 25 | $833.8M | $11.3B | ||
| Q1 25 | $789.2M | $12.6B | ||
| Q4 24 | $764.9M | $12.9B | ||
| Q3 24 | $732.5M | $13.6B | ||
| Q2 24 | $706.5M | $13.9B | ||
| Q1 24 | $856.2M | $14.0B |
| Q4 25 | $2.2B | $19.6B | ||
| Q3 25 | $2.2B | $19.1B | ||
| Q2 25 | $2.1B | $20.5B | ||
| Q1 25 | $2.0B | $21.4B | ||
| Q4 24 | $2.2B | $20.3B | ||
| Q3 24 | $2.1B | $20.9B | ||
| Q2 24 | $2.0B | $21.7B | ||
| Q1 24 | $2.2B | $22.3B |
| Q4 25 | 0.66× | 0.57× | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | 0.41× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $186.0M |
| Free Cash FlowOCF − Capex | — | $-88.0M |
| FCF MarginFCF / Revenue | — | -35.3% |
| Capex IntensityCapex / Revenue | — | 110.0% |
| Cash ConversionOCF / Net Profit | 3.39× | 6.64× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-219.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $186.0M | ||
| Q3 25 | $137.3M | $231.0M | ||
| Q2 25 | $137.2M | $232.0M | ||
| Q1 25 | $-117.5M | $90.0M | ||
| Q4 24 | $133.0M | $283.0M | ||
| Q3 24 | $91.8M | $208.0M | ||
| Q2 24 | $107.0M | $231.0M | ||
| Q1 24 | $-125.2M | $78.0M |
| Q4 25 | — | $-88.0M | ||
| Q3 25 | — | $-283.0M | ||
| Q2 25 | — | $151.0M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $231.0M | ||
| Q3 24 | — | $152.0M | ||
| Q2 24 | — | $162.0M | ||
| Q1 24 | — | $14.0M |
| Q4 25 | — | -35.3% | ||
| Q3 25 | — | -89.8% | ||
| Q2 25 | — | 44.2% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 78.6% | ||
| Q3 24 | — | 47.6% | ||
| Q2 24 | — | 45.0% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | 110.0% | ||
| Q3 25 | — | 163.2% | ||
| Q2 25 | — | 23.7% | ||
| Q1 25 | — | 31.6% | ||
| Q4 24 | — | 17.7% | ||
| Q3 24 | — | 17.6% | ||
| Q2 24 | — | 19.2% | ||
| Q1 24 | — | 24.9% |
| Q4 25 | 3.39× | 6.64× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | 2.94× | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | 3.73× | ||
| Q1 24 | -31.03× | 1.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
XIFR
| Renewable Energy Sales | $238.0M | 96% |
| Related Party | $8.0M | 3% |